Experimental Drug for Hepatitis C Promising, Studies Show

A new treatment for difficult-to-treat hepatitis C has higher cure rates, takes less time and causes fewer side effects than the current therapy, new research finds. When the new drug, sofosbuvir, is combined with the medication ribavirin, cure rates are as high as traditional therapy, which pairs ribavirin and pegylated interferon, the researchers say. But patients taking sofosbuvir — a once-a-day pill — are spared the severe side effects associated with interferon.

Source: http://www.dentapress.com/headlines/5146-experimental-drug-for-hepatitis-c-promising-studies-show.html

dental implant surgery mouth surgery tooth implant procedure dental news dental implant procedure